Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research
Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research Business Wire
1636 материалов по теме, собраны автоматически из проверенных источников
Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research Business Wire
Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research Yahoo Finance
Препарат замедлил рост опухолей у мышей в исследовании рака легких — News-Medical UA.NEWS
LG Chem Takes AI Into Clinical Patient Selection, Targets 2029 Trial for Personalized Cancer Vaccine BigGo Finance
After the Applause: Six ESMO Trials that Changed Cancer Treatment Oncodaily
Research report: Revisiting Ehrlich carcinoma in the era of precision Bioengineer.org
Рак мочевого пузыря у взрослых: нужно применять новые клинические рекомендации consultant.ru
Gateway for Cancer Research Celebrates 35 Years of Hope and Innovation at 2026 Cures Gala USA Today
Scientists co-led by St. Jude Children's Research Hospital have identified a potential therapeutic vulnerability in some forms of osteosarcoma. A combination approach described today in the Journal of Experimental Medicine slowed tumor growth and prolonged survival in preclinical models of this pediatric bone cancer…
ИИ научился оценивать риск смерти от рака по фотографии лица: новое исследование Газета Балаково
“Cancer research really does make a difference. I’m living proof!” insurance-portal.ca
People who develop pancreatic cancer experience measurable changes in body composition years before diagnosis that differ from those seen in similar individuals without cancer, according to a Mayo Clinic study led by former Mayo Clinic research fellow Aleksander Bogdanski and published in Pancreatology.
Telemedicine helps reduce admissions, cut costs for cancer patients, study finds Healthcare IT News
Gateway for Cancer Research Celebrates 35 Years of Hope and Innovation at 2026 Cures Gala Fortune
Edison Oncology Appoints Michael Faber to Board of Directors, Announces Five Oncology Research Presentations citybiz